“Cellufacturing”: 108Labs targets 99% cost decrease in cell-based infant formula

Cell-based formula moves from lab to factory as CEO eyes cost reduction and scalability

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

With inflationary pressures reaching record highs, governments, consumers, and businesses alike are clambering to mitigate the consequences of the inevitable cost hikes.... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

As the US Food and Drug Administration (FDA) implements its greater flexibility strategy to curb US infant formula shortages, imports from Ireland-based Abbott Nutrition... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

The US Food and Drug Administration (FDA) is investigating another death potentially linked to Abbott infant formula. The revelations come amid an ongoing probe over two... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Abbott has stopped producing EleCare specialty formula at its Sturgis plant in Michigan, US, after parts of it were flooded following heavy thunderstorms. The move will... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Food Standards Australia New Zealand (FSANZ) has approved Chr. Hansen’s 2’-FL human milk oligosaccharide (HMO) for infant formula, paving the way for the... Read More

trans